#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Rising incidence and mortality with #prostatecancer in Africa👉key will be to improve early detection (most diagnosed and biopsies through digital exam), improve access to radiotherapy, develop local Rx guidelines👇 OncoAlert Abeid Athman PCF Science

APCCC debate with Thomas Zilli and Pierre Blanchard covering radiation therapy for metastatic disease from Lugano. Thanks to Neeraj Agarwal, MD, FASCO for help with the tweet. #APCCC2024 OncoAlert . t.ly/D7N0_

Check out our APCCC podcasts with Jason Efstathiou and Piet Ost discuss the data for and against adjuvant radiotherapy. podcasters.spotify.com/pod/show/the-u…

Thanks Manmeet Ahluwalia, MD, MBA, FASCO for visiting us! Always great to catch up with you and get words of wisdom!
#Cleveland Cleveland Clinic MD Case Comp Cancer Ctr Miami Cancer Institute Research Harneet Walia

Congrats Manmeet Ahluwalia, MD, MBA, FASCO on this honor! Your insights and wisdom on leadership in healthcare are unparalleled!

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 outstanding talk by the super star Vedang Murthy from Tata Memorial Hospital , Mumbai 👉challenges faced by oncology docs in India & solutions👉Simplify care, improve access, & remarkable advances in telemedicine 👇OncoAlert silke gillessen NationalCancerGrid

It is my privilege to be the keynote speaker at the Inaugural
Healthcare Distinguished Speaker Series Weatherhead School (my Alma mater) on 'the New Era of Strategic Leadership for Healthcare'. Baptist Health Miami Cancer Institute Research Case Comp Cancer Ctr Cleveland Clinic

⁦Tom Powles⁩ and I are at the amazing APCCC prostate meeting. Stay tuned for some special podcasts from Lugano!!

Nick James Thanks Nick. This will only happen when we all as investigators (and with patient advocacy) refuse to do such trials when offered to us. We all need to do better because it’s 2024 and we know this should no longer be acceptable in trial design / registration strategy. #APCCC24

Ian Davis makes the really important point about ARPI switch not being an acceptable control in licensing studies #APCCC24

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Excellent points raised by Ian Davis on sequencing of Rx in metastatic #prostatecancer 👉key principles & his suggestions for sequencing of Rx👇OncoAlert PCF Science silke gillessen

Honored to receive this award, and a
copy of the wonderful painting by vincentdevineart with amazing imagery representing the themes and collaborations of the #EuroAmericanCancerForum2024 #TogetherStronger #CancerHasNoBorders

Looking for teams for #uromigoslive24 to take on the team from LA. Hard it beat Tanya, Monty and Petros…..

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 outstanding talk by Nick James on triplet vs doublet therapy in mCSPC #ProstateCancer 👉gives shoutout to network meta-analysis by SOUMYAJIT ROY 👉value of triplet unclear in all pts, pts QOL should be considered OncoAlert silke gillessen

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Michael Morris Mike Morris👉Regular conventional imaging is must in pts with mCSPC #ProstateCancer 👉Arches trial data showed imaging progression (minus PSA rise) in many, and lineage plasticity makes PSA/PSMA unreliable. OncoAlert silke gillessen

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Sandy Srinivas ‘s wonderful talk on the role of radiation to the prostate in high volume mCSPC #ProstateCancer 👉QOL benefit may justify RT in these patients👇OncoAlert PCF Science silke gillessen

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 What to do with #ProstateCancer with biochemical (PSA) recurrence with PSA doubling time >9 months? 👉check testosterone level and personalize treatment 👇 Excellent perspective 👇 by Ransom McDermott OncoAlert UroToday.com silke gillessen

#APCCC24 Advanced Prostate Cancer Consensus Conference starts with the introduction by silke gillessen aurelius omlin 👉International, diverse panel👇 with world experts in #ProstateCancer , planning committee and upcoming APCCC events 👇 OncoAlert UroToday.com PCF Science

#APCCC24 Advanced Prostate Cancer Consensus Conference outstanding talk by Daniel E Spratt on personalization of Rx in localized #ProstateCancer 👉Role of AI based biomarkers and genomic classifiers for de-
and escalation of Rx 👇 OncoAlert UroToday.com silke gillessen Neha Vapiwala aurelius omlin

#APCCC24 Advanced Prostate Cancer Consensus Conference Fantastic talk by Neha Vapiwala on radiation Rx in high risk #ProstateCancer :more or less? 👉role of ultra-fractionated, micro boost RT? Increasing use of genomic biomarkers in dose determination OncoAlert PCF Science silke gillessen